Mahfouz Basith


+1 212 479 6649

Mahfouz Basith’s practice focuses on the representation of both issuers and investment banks on a variety of capital markets and corporate transactions, including initial public offerings, follow-on offerings, “at-the-market” offerings, and convertible debt offerings. Mahfouz also regularly counsels public companies with respect to general corporate matters, including SEC reporting and corporate governance. 

Download full bio


  • Prevail Therapeutics Closes $50 Million Series B 

  • SpringWorks Therapeutics – $186 Million IPO  

  • Prevail Therapeutics $125 Million IPO 

  • Bicycle Therapeutics - $61 Million IPO 


  • Columbia Law School
    JD, 2016

  • Columbia College, Columbia University
    BA, Political Science and Middle Eastern, South Asian and African Studies

Admissions & Credentials

New York


+1 212 479 6649 office

55 Hudson Yards
New York, NY 10001-2157